Connection
Rohit Katial to Insurance, Health, Reimbursement
This is a "connection" page, showing publications Rohit Katial has written about Insurance, Health, Reimbursement.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.051 |
|
|
|
-
Xu X, Schaefer C, Szende A, Genofre E, Katial R, Chung Y. A cost comparison of benralizumab, mepolizumab, and dupilumab in patients with severe asthma: A US third-party payer perspective. J Manag Care Spec Pharm. 2023 Nov; 29(11):1193-1204.
Score: 0.051